Normal view MARC view ISBD view

Could therapeutic drug monitoring of anti-TNF-α be useful to consider a de-escalation of treatment?

Flamant, Mathurin

Could therapeutic drug monitoring of anti-TNF-α be useful to consider a de-escalation of treatment? [electronic resource] - Expert opinion on biological therapy 2015 - 1657-60 p. digital

Publication Type: Editorial

ISSN: 1744-7682

Standard No.: 10.1517/14712598.2015.1069273 doi

Subjects--Topical Terms:
Azathioprine--metabolism
Drug Monitoring
Humans
Immunologic Factors--metabolism
Inflammatory Bowel Diseases--drug therapy
Infliximab--metabolism
Recurrence
Tumor Necrosis Factor-alpha--immunology

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)